Endo Pharmaceuticals and LecTec Settle Patent Dispute (redOrbit)

Endo Pharmaceuticals and LecTec Settle Patent Dispute (redOrbit)
CHADDS FORD, Pa., Nov. 11 /PRNewswire-FirstCall/ — Endo Pharmaceuticals (Nasdaq: ENDP) announced today that it has reached a settlement with LecTec Corporation on outstanding patent litigation related to LecTec’s U.S. Patent Nos.